Home > Seno Medical Instruments Salary

Seno Medical Instruments Salary

  • 100
  • 53
  • 62
Seno Medical Instruments average salary is $256,000, median salary is $256,000 with a salary range from $200,000 to $312,000.
Seno Medical Instruments salaries are collected from government agencies and companies. Each salary is associated with a real job position. Seno Medical Instruments salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 1 Seno Medical Instruments Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Medical Director 200,000-312,000 San Antonio, TX, 78201 2018 Seno Medical Instruments Medical Director Salaries (2)
Seno Medical Instruments San Antonio, TX Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Seno Medical Instruments salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Seno Medical Instruments Jobs
See more Seno Medical Instruments Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
Seno Medical Instrumen... Information
  • Seno Medical Instruments Inc
  • Industry: Medical Equipment
  • City: San Antonio, TX
  • Seno Medical, Inc. was formed to commercialize a new modality in cancer screening and diagnosis: laser opto-acoustic imaging. Unlike most screening techniques, which rely on anatomical imaging, Seno's goal is to bring functional imaging that can detect angiogenesis to the marketplace. Our first product is a small animal imaging device, now in testing and scheduled for release in spring 2007. Products for use with humans, focusing initially on breast cancer, are also in development for subsequent testing.